Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.
Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.
Susan Sieber, Former NCI Communications Chief, Dead.
Andrew von Eschenbach Sworn In As NCI Director.
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.
FDA Approves Abbott’s HER-2 DNA Probe Kit.
Univ. Of Pittsburgh Plans Molecular Medicine Institute.
Trending Stories
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
- The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience
“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” - Reflections of a cancer scientist
Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - NCI releases names of members of ad hoc working group—filling the void left by BSA
- Nobel laureate David Baltimore dies at 87
Baltimore discovered that genetic material of tumor viruses could make DNA from their RNA genome